Background: Alzheimer's disease (AD) and Multiple sclerosis (MS) lead to neurodegenerative processes negatively affecting millions of people worldwide. Their treatment is still difficult and practically incomplete. One of the most commonly used drugs against these neurodegenerative diseases is 4-aminopyridine.
View Article and Find Full Text PDFBackground: Inhibitors of acetylcholinesterase (AChE) are used to treat many disorders, among which are neurodegenerative upsets, like Alzheimer's disease (AD). One of the limited licensed AChE inhibitors (AChEIs) used as drugs is the natural compound galantamine (Gal).
Objective: As Gal is a toxic compound, here we expose data about its four derivatives in hybrid peptide-norgalantamine molecules, which have shown 100 times lower toxicity.
Herein, studies on the surface activities of newly synthesized l-Asp-based gemini surfactants, both nonionic and anionic, are presented. Conductometry, tensiometry, and the Langmuir-Blodgett (LB) film technique were applied for this purpose. - isotherms were obtained with a Langmuir trough and Wilhelmy balance.
View Article and Find Full Text PDFBackground: Although no effective treatment for the Alzheimer's disease currently exist, some drugs acting as Acetylcholinesterase inhibitors, like galanthamine have positively affected such patients. β- and/or γ-secretase inhibitors are another type of potential drugs. Here we report synthesis of new peptide-galanthamine derivatives, with expected inhibitory activity against both Acetylcholinesterase and β-secretase.
View Article and Find Full Text PDFProtein Pept Lett
August 2005
From the experimentally defined rate of heterogeneous formation of protein crystals and number of collisions between protein molecules with substrate, the energy barrier for adhesion of protein molecule to alien materials is estimated. According to the Boltzmann equation for energy distribution this barrier is of the order of 10(-12) erg per molecule.
View Article and Find Full Text PDF